GeoVax Labs, Inc.
GOVX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.03 | 0.01 | 0.06 |
| FCF Yield | -64.71% | -32.60% | -47.08% | -29.79% |
| EV / EBITDA | -0.73 | -1.91 | -0.98 | -2.49 |
| Quality | ||||
| ROIC | -129.88% | -192.08% | -68.44% | -165.28% |
| Gross Margin | 0.00% | 100.00% | 98.97% | 97.50% |
| Cash Conversion Ratio | 0.98 | 0.81 | 1.11 | 0.94 |
| Growth | ||||
| Revenue 3-Year CAGR | 1,496,716.95% | 1,831,347.79% | 1,774,802.62% | 264.70% |
| Free Cash Flow Growth | -43.32% | 27.34% | 23.06% | 16.79% |
| Safety | ||||
| Net Debt / EBITDA | 0.79 | 0.58 | 1.39 | 0.67 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -5,230.15 | 56.26 | -12,699.04 | -7,624.08 |